Featured Education

nmdp-mds3_1729518959
soho-2024-enduring-banner-445x250-02-02-02_1727985795
p24011-lms-thumb_1726675197
P23033 LMS Thumb
p24034-obesity-aafp-lms-thumbnail-445x250px_1723738749
lms-thumbnail-445-x-250_1720799794

On Demand Activities

Therapeutics Areas
Learner Specialties
Expires After
The Evolution of HCT, Part 1: Basics and Outcomes
Community hematology/oncology practices play a critical role to expand patient access to hematopoietic cell transplantation (HCT) and improve patient outcomes. This self-guided online training course series consists of five courses designed to present the current state of the science for Hematopoietic Cell Transplantation (HCT) by following the evolution of HCT over time. The series is broken down into major misperceptions or myths about HCT and cellular therapy that are not supported by current research and clinical practice. This is Part 1 in a 5-part series, including the series introduction, basics of HCT, and major advances in HCT outcomes over time.
Beyond Inertia: Advancing T2D Care With Innovative Basal Insulin Strategies
Discover the forefront of diabetes care at Diabetes Dialogues LIVE, targeting the latest in once-weekly basal insulin therapy, including unique mechanism of action and pharmacokinetic/pharmacodynamic properties. Join fellow endocrinologists to unpack recent safety and efficacy data. Additionally, hear discussion about basal insulin therapy for patient care and how to best ensure adherence through effective T2D management. Delve into clinical trials outcomes, glycemic control, weight management, and hypoglycemia risks. Engage in essential scientific discourse to shape the future of diabetes treatment. Do not miss this event for an insightful blend of data and practice. This activity is derived from the Live ISS Meeting at ENDO, originally held on June 1, 2024.
Shared Decision Making
It is a process that fosters shared decision making that includes exploring and comparing the benefits, harms, and risks of each health care option through meaningful dialogue about what matters most to the patient. The doctor and patient need to use evidence-based information while working together to make the best possible treatment decisions.
Recognizing the Profound Impact on Quality of Life: Emerging Therapy Options for Patients with Myelofibrosis
In this combined enduring and live ONS chapter meeting activity, Recognizing the Profound Impact on Quality of Life: Emerging Therapy Options for Patients with Myelofibrosis, learn from expert faculty to effectively identify how JAK inhibitors and emerging treatments for myelofibrosis (MF) optimize clinical outcomes by improving overall patient quality of life (QOL). Learners will first participate in an enduring online program on the following topics: patient risk and drug mechanisms of action for effective treatment and management, gaps in MF care that influence patient QOL, disease- and treatment-related adverse events, trust with patients to improve outcomes and QOL, shared decision-making and the unique role of multidisciplinary teams. After completion of the enduring program, learners will have the opportunity to network with expert faculty at select live ONS chapter meetings at which time they will discuss various case studies regarding treatment selection and patient QOL. Learners will also participate in discussion questions and have time for one-on-one interaction with faculty and others nursing professionals.
Delivering Patient Centered Care
Patient-centered care is a model of care that respects the patient’s experience, values, needs and preferences in the planning, coordination and delivery of care. A central component of this model is a therapeutic relationship between the patient and the team of healthcare professionals. The implementation of a patient-centered care model has been shown to contribute to improved outcomes for patients, better use of resources, decreased costs and increased satisfaction with care. This article provides an overview of the barriers to providing patient-centered care and identifies strategies that can be implemented to overcome them.
Build Your Own Case Study | From Evidence to Practice: Enhancing T2D Outcomes with Informed Approaches on Obesity
The tie between type 2 diabetes (T2D) and overweight/obesity is a significant global public health issue, supported by decades of extensive research. Despite formal clinical guidelines recommendations in addressing both diseases, the initiation or intensification of therapies that improve glycemic control and achieve weight reduction targets are slowly adopted into clinical practice, particularly for patients with T2D. Given the overlap of these two conditions, it is imperative that healthcare providers worldwide align clinical practice with evidence-based guidelines and the latest clinical findings using newer agents to treat both diseases.
Scroll to Top